BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22359291)

  • 41. Emerging Epigenetic Therapies for Brain Tumors.
    Kukreja L; Li CJ; Ezhilan S; Iyer VR; Kuo JS
    Neuromolecular Med; 2022 Mar; 24(1):41-49. PubMed ID: 34677796
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective.
    de Bont JM; Packer RJ; Michiels EM; den Boer ML; Pieters R
    Neuro Oncol; 2008 Dec; 10(6):1040-60. PubMed ID: 18676356
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The necessity of a human epigenome project.
    Esteller M
    Carcinogenesis; 2006 Jun; 27(6):1121-5. PubMed ID: 16699174
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Loss of pericentromeric DNA methylation pattern in human glioblastoma is associated with altered DNA methyltransferases expression and involves the stem cell compartment.
    Fanelli M; Caprodossi S; Ricci-Vitiani L; Porcellini A; Tomassoni-Ardori F; Amatori S; Andreoni F; Magnani M; De Maria R; Santoni A; Minucci S; Pelicci PG
    Oncogene; 2008 Jan; 27(3):358-65. PubMed ID: 17653095
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pediatric Brain Tumors: An Update.
    Segal D; Karajannis MA
    Curr Probl Pediatr Adolesc Health Care; 2016 Jul; 46(7):242-250. PubMed ID: 27230809
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions.
    Agnihotri S; Zadeh G
    Neuro Oncol; 2016 Feb; 18(2):160-72. PubMed ID: 26180081
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Mutations in histone H3.3 and chromatin remodeling genes drive pediatric and young adult glioblastomas].
    Khuong-Quang DA; Gerges N; Jabado N
    Med Sci (Paris); 2012 Oct; 28(10):809-12. PubMed ID: 23067407
    [No Abstract]   [Full Text] [Related]  

  • 48. Sulfonylurea receptor 1 expression is variable in adult and pediatric brain tumors.
    Thompson EM; Halvorson K; McLendon R
    Clin Neuropathol; 2018; 37(5):221-227. PubMed ID: 30079884
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of the P
    Frankel BM; Cachia D; Patel SJ; Das A
    J Mol Neurosci; 2021 Aug; 71(8):1714-1722. PubMed ID: 33595778
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DNA methylation-based age estimation in pediatric healthy tissues and brain tumors.
    Kling T; Wenger A; Carén H
    Aging (Albany NY); 2020 Nov; 12(21):21037-21056. PubMed ID: 33168783
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Medulloblastoma epigenetics and the path to clinical innovation.
    Haltom AR; Toll SA; Cheng D; Maegawa S; Gopalakrishnan V; Khatua S
    J Neurooncol; 2020 Oct; 150(1):35-46. PubMed ID: 32816225
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pediatric brain tumor cell lines.
    Xu J; Margol A; Asgharzadeh S; Erdreich-Epstein A
    J Cell Biochem; 2015 Feb; 116(2):218-24. PubMed ID: 25211508
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Weighing ependymoma as an epigenetic disease.
    Stuckert A; Bertrand KC; Wang P; Smith A; Mack SC
    J Neurooncol; 2020 Oct; 150(1):57-61. PubMed ID: 32964355
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Into Thin Air: Hypoxia Drives Metabolic and Epigenomic Deregulation of Lethal Pediatric Ependymoma.
    Englinger B; Hack OA; Filbin MG
    Dev Cell; 2020 Jul; 54(2):134-136. PubMed ID: 32693052
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The S-100 protein in water-soluble and pentanol-extractable form in normal human brain and tumours of the human nervous system. A quantitative study.
    Haglid KG; Stavrou D; Rönnbäck L; Carlsson CA; Weidenbach W
    J Neurol Sci; 1973 Sep; 20(1):103-11. PubMed ID: 4355340
    [No Abstract]   [Full Text] [Related]  

  • 56. Exploiting Laboratory Insights to Improve Outcomes of Pediatric Central Nervous System Tumors.
    Robinson GW; Witt H; Resnick A
    Am Soc Clin Oncol Educ Book; 2016; 35():e540-6. PubMed ID: 27249765
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Amplification, rearrangement and over-expression of c-fos gene in human primary brain tumors].
    Wen Y; Sun ZL; Liao WM; Zhou RX
    Hua Xi Yi Ke Da Xue Xue Bao; 1989 Sep; 20(3):243-5. PubMed ID: 2560457
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The genetic and epigenetic basis of ependymoma.
    Mack SC; Taylor MD
    Childs Nerv Syst; 2009 Oct; 25(10):1195-201. PubMed ID: 19536551
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genomics and epigenetics: A study of ependymomas in pediatric patients.
    Pérez-Ramírez M; Hernández-Jiménez AJ; Guerrero-Guerrero A; Benadón-Darszon E; Pérezpeña-Díazconti M; Siordia-Reyes AG; García-Méndez A; de León FC; Salamanca-Gómez FA; García-Hernández N
    Clin Neurol Neurosurg; 2016 May; 144():53-8. PubMed ID: 26971296
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recent perspectives of ependymomas (childhood brain tumors).
    Zeng ZD; Liu FL; Li SX
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(4 Suppl):13-19. PubMed ID: 29165771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.